Jackson Hoesley
Researcher
Also affiliated: University of Alabama at Birmingham (2022)
Graduate Student Researcher
Research Areas
Biography and Research Information
OverviewAI-generated summary
Jackson Hoesley's research focuses on the prognostic significance of biomarkers and the diagnostic performance of functional assays. His work has investigated the neutrophil-to-lymphocyte ratio as a prognostic indicator in small cell lung cancer, particularly in the context of immunotherapy treatment. Additionally, Hoesley has examined the real-world performance of assays used in the diagnosis of Heparin-Induced Thrombocytopenia (HIT), including the PF4-dependent P-Selectin Expression Assay (PEA) and the Serotonin Release Assay (SRA). These studies contribute to understanding diagnostic tool effectiveness and patient outcome prediction in clinical settings. Hoesley collaborates with researchers at the University of Arkansas for Medical Sciences, including Jacob T. Wooldridge, Konstantinos Arnaoutakis, and Bhavesh Mohan Lal.
Metrics
- Publications: 3
Selected Publications
-
Prognostic significance of neutrophil-to-lymphocyte ratio in small cell lung cancer in the era of immunotherapy. (2025)
-
The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT) (2024)
Collaboration Network
Top Collaborators
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- Prognostic significance of neutrophil-to-lymphocyte ratio in small cell lung cancer in the era of immunotherapy.
- Prognostic significance of neutrophil-to-lymphocyte ratio in small cell lung cancer in the era of immunotherapy.
- Prognostic significance of neutrophil-to-lymphocyte ratio in small cell lung cancer in the era of immunotherapy.
Similar Researchers
Based on overlapping research topics